Los Angeles Capital Management LLC Clovis Oncology, Inc. Transaction History

Los Angeles Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 11, 2019	SELL	$11.63 - $32.67 $95,296 - $267,697	-8,194 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$29.37 - $49.48 $1.22 Million - $2.06 Million	-41,655 Reduced 83.56%	8,194 $241,000
Q2 2018 Jul 31, 2018	BUY	$42.06 - $62.4 $589,891 - $875,160	14,025 Added 39.15%	49,849 $2.27 Million
Q1 2018 Apr 27, 2018	BUY	$50.12 - $67.72 $725,988 - $980,924	14,485 Added 67.88%	35,824 $1.89 Million
Q4 2017 Feb 05, 2018	BUY	$57.69 - $84.58 $549,266 - $805,286	9,521 Added 80.56%	21,339 $1.45 Million
Q3 2017 Nov 06, 2017	BUY	$67.17 - $84.81 $793,815 - $1 Million	11,818	11,818 $974,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.